<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="78a3bdb0-c945-45cf-b75d-066dbf1d152c"><labelDrug name="Tekamlo"><Normalization><mmtx cui="C2939825" preferredWord="Tekamlo" semType="phsu"/></Normalization></labelDrug><generic name="Aliskiren Hemifumarate and Amlodipine Besylate"/><sentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.13" text="Tekamlo is indicated for the treatment of hypertension, alone or with other antihypertensive agents, to lower blood pressure. " type="negative"><entity charOffset="0:7" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.13.e.0" text="tekamlo" type="Biomedical_Entity"><Normalization><mmtx cui="C2939825" phraseText="Tekamlo" preferredWord="Tekamlo" semType="phsu"/><RxNorm RxCui="1372707"/></Normalization></entity><entity charOffset="76:99" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.13.e.1" text="antihypertensive agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="or with other antihypertensive agents," preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.13.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.13.e.1"/></sentence><sentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.15" text="These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including amlodipine. " type="negative"><entity charOffset="132:142" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.15.e.0" text="amlodipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0051696" phraseText="amlodipine." preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><entity charOffset="54:76" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.15.e.1" text="antihypertensive drugs" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="seen in controlled trials of antihypertensive drugs" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.15.e.1" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.15.e.0"/></sentence><sentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.26" text="Data from the high-dose multifactorial study see Clinical Studies (14) provide estimates of the probability of reaching a target blood pressure with Tekamlo compared to aliskiren or amlodipine monotherapy. " type="negative"><entity charOffset="182:192" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.26.e.0" text="amlodipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0051696" phraseText="amlodipine monotherapy." preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><entity charOffset="149:156" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.26.e.1" text="tekamlo" type="Biomedical_Entity"><Normalization><mmtx cui="C2939825" phraseText="a target blood pressure with Tekamlo" preferredWord="Tekamlo" semType="phsu"/><RxNorm RxCui="1372707"/></Normalization></entity><entity charOffset="169:178" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.26.e.2" text="aliskiren" type="Biomedical_Entity"><Normalization><mmtx cui="C1120110" phraseText="compared to aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.26.e.1" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.26.e.0"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.26.e.2" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.26.e.0"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.26.e.1" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.26.e.2"/></sentence><sentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.33" text="A patient with a baseline blood pressure of 157/100 mmHg has about a 49% likelihood of achieving a goal of 140 mmHg (systolic) and 50% likelihood of achieving 90 mmHg (diastolic) on aliskiren alone, and the likelihood of achieving these goals on amlodipine alone is about 62% (systolic) and 69% (diastolic). " type="negative"><entity charOffset="182:191" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.33.e.0" text="aliskiren" type="Biomedical_Entity"><Normalization><mmtx cui="C1120110" phraseText="on aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="246:256" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.33.e.1" text="amlodipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0051696" phraseText="these goals on amlodipine" preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.33.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.33.e.1"/></sentence><sentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.37" text="is a combination of aliskiren, a renin inhibitor, and amlodipine, a dihydropyridine calcium channel blocker, indicated for the treatment of hypertension, to lower blood pressure:" type="negative"><entity charOffset="33:48" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.37.e.0" text="renin inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C3537174" phraseText="a renin inhibitor," preferredWord="Renin Inhibitor [EPC]" semType="phsu"/><RxNorm RxCui="9246"/></Normalization></entity><entity charOffset="20:29" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.37.e.1" text="aliskiren" type="Biomedical_Entity"><Normalization><mmtx cui="C1120110" phraseText="a combination of aliskiren," preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="54:64" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.37.e.2" text="amlodipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0051696" phraseText="amlodipine," preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><entity charOffset="68:107" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.37.e.3" text="dihydropyridine calcium channel blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C2945601" phraseText="a dihydropyridine calcium channel blocker," preferredWord="Dihydropyridine Calcium Channel Blocker [EPC]" semType="phsu"/><RxNorm RxCui="3427"/></Normalization></entity><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.37.e.1" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.37.e.0"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.37.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.37.e.2"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.37.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.37.e.3"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.37.e.1" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.37.e.2"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.37.e.1" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.37.e.3"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.37.e.2" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.37.e.3"/></sentence><sentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.63" text="Use Tekamlo for patients not adequately controlled with aliskiren alone or amlodipine besylate (or another dihydropyridine calcium channel blocker) alone." type="negative"><entity charOffset="4:11" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.63.e.0" text="tekamlo" type="Biomedical_Entity"><Normalization><mmtx cui="C2939825" phraseText="Use Tekamlo for patients" preferredWord="Tekamlo" semType="phsu"/><RxNorm RxCui="1372707"/></Normalization></entity><entity charOffset="75:94" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.63.e.1" text="amlodipine besylate" type="Biomedical_Entity"><Normalization><mmtx cui="C0354468" phraseText="amlodipine besylate" preferredWord="Amlodipine Besylate" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><entity charOffset="107:146" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.63.e.2" text="dihydropyridine calcium channel blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C2945601" phraseText="another dihydropyridine calcium channel blocker" preferredWord="Dihydropyridine Calcium Channel Blocker [EPC]" semType="phsu"/><RxNorm RxCui="3427"/></Normalization></entity><entity charOffset="56:65" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.63.e.3" text="aliskiren" type="Biomedical_Entity"><Normalization><mmtx cui="C1120110" phraseText="controlled with aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.63.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.63.e.1"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.63.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.63.e.2"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.63.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.63.e.3"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.63.e.1" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.63.e.2"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.63.e.3" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.63.e.1"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.63.e.3" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.63.e.2"/></sentence><sentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.65" text="Switch patients receiving aliskiren and amlodipine besylate from separate tablets to a single tablet of Tekamlo containing the same component doses. " type="negative"><entity charOffset="40:59" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.65.e.0" text="amlodipine besylate" type="Biomedical_Entity"><Normalization><mmtx cui="C0354468" phraseText="amlodipine besylate from separate tablets" preferredWord="Amlodipine Besylate" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><entity charOffset="104:111" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.65.e.1" text="tekamlo" type="Biomedical_Entity"><Normalization><mmtx cui="C2939825" phraseText="of Tekamlo" preferredWord="Tekamlo" semType="phsu"/><RxNorm RxCui="1372707"/></Normalization></entity><entity charOffset="26:35" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.65.e.2" text="aliskiren" type="Biomedical_Entity"><Normalization><mmtx cui="C1120110" phraseText="aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.65.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.65.e.1"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.65.e.2" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.65.e.0"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.65.e.2" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.65.e.1"/></sentence><sentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.67" text="Tekamlo may be administered with some other antihypertensive agents. " type="negative"><entity charOffset="44:67" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.67.e.0" text="antihypertensive agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="other antihypertensive agents." preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="0:7" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.67.e.1" text="tekamlo" type="Biomedical_Entity"><Normalization><mmtx cui="C2939825" phraseText="Tekamlo" preferredWord="Tekamlo" semType="phsu"/><RxNorm RxCui="1372707"/></Normalization></entity><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.67.e.1" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.67.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.68" lineNumber="66" text="In diabetics, do not use in combination with angiotensin receptor blockers (ARBs) or angiotensin converting enzyme inhibitors (ACEIs) see Contraindications (4). " type="irregular"><entity charOffset="3:12" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.68.e.0" text="diabetics" type="SPAN"/><entity charOffset="14:24" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.68.e.1" text="do not use" type="Caution_Interaction"/><entity charOffset="45:81" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.68.e.3" text="angiotensin receptor blockers (ARBs)" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="with angiotensin receptor blockers (ARBs)" preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><mmtx cui="C0815017" phraseText="with angiotensin receptor blockers (ARBs)" preferredWord="Angiotensin Receptor Antagonists" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="85:133" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.68.e.4" text="angiotensin converting enzyme inhibitors (ACEIs)" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="angiotensin converting enzyme inhibitors (ACEIs)" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.68.ddi.1"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.68.e.1"><relations><relation type="hasContext"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.68.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.68.e.3"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.67" text="Tekamlo may be administered with some other antihypertensive agents. "><entity charOffset="0:7" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.67.e.0" text="Tekamlo" type="Drug"><Normalization><mmtx cui="C2939825" phraseText="Tekamlo" preferredWord="Tekamlo" semType="phsu"/></Normalization></entity></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.68.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.68.e.3" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.68.e.4"/><pair ddi="true" e1="labelDrug" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.68.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.68.e.4"/></sentence><sentence biomedicalEntities="3" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.69" lineNumber="66" text="Concomitant use of aliskiren with an ARB or ACEI is not recommended in patients with GFR 60 ml/min see Warnings and Precautions (5.2). " type="regular"><entity charOffset="19:28" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.69.e.0" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="Concomitant use of aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="37:40" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.69.e.1" text="ARB" type="Drug_Class"><Normalization><RxNorm RxCui="1149617"/></Normalization></entity><entity charOffset="44:48" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.69.e.2" text="ACEI" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="52:67" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.69.e.3" text="not recommended" type="Caution_Interaction"/><entity charOffset="71:98" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.69.e.5" text="patients with GFR 60 ml/min" type="SPAN"/><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.69.ddi.1"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.69.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.69.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.69.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.69.e.0"/></relation><relation type="hasContext"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.69.e.5"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.69.e.5" ddi="true" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.69.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.69.e.1" trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.69.e.3" type="Caution_Interaction"/><pair context="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.69.e.5" ddi="true" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.69.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.69.e.2" trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.69.e.3" type="Caution_Interaction"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.69.e.1" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.69.e.2"/></sentence><sentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.70" text="It is not known whether Tekamlo decreases blood pressure further when added to maximum dosages of ACE inhibitors and beta blockers see Clinical Studies (14)." type="negative"><entity charOffset="24:31" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.70.e.0" text="tekamlo" type="Biomedical_Entity"><Normalization><mmtx cui="C2939825" phraseText="Tekamlo" preferredWord="Tekamlo" semType="phsu"/><RxNorm RxCui="1372707"/></Normalization></entity><entity charOffset="98:112" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.70.e.1" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="added to maximum dosages of ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="117:130" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.70.e.2" text="beta blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="beta blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.70.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.70.e.1"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.70.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.70.e.2"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.70.e.1" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.70.e.2"/></sentence><sentence biomedicalEntities="3" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.74" lineNumber="71" text="Do not use aliskiren with ARBs or ACEIs in patients with diabetes see Warnings and Precautions (5.2), Clinical Studies (14.2)." type="regular"><entity charOffset="11:20" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.74.e.0" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with ARBs" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="26:30" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.74.e.1" text="ARBs" type="Drug_Class"><Normalization><RxNorm RxCui="1149617"/></Normalization></entity><entity charOffset="34:39" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.74.e.2" text="ACEIs" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="57:65" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.74.e.3" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes" preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes" preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><entity charOffset="0:10" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.74.e.4" text="Do not use" type="Caution_Interaction"/><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.74.ddi.1"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.74.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.74.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.74.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.74.e.0"/></relation><relation type="hasContext"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.74.e.3"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.74.e.3" ddi="true" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.74.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.74.e.1" trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.74.e.4" type="Caution_Interaction"/><pair context="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.74.e.3" ddi="true" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.74.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.74.e.2" trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.74.e.4" type="Caution_Interaction"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.74.e.1" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.74.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.76" lineNumber="73" text="Do not use with angiotensin receptor blockers (ARBs) or ACE inhibitors (ACEIs) in patients with diabetes (4)" type="irregular"><entity charOffset="0:10" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.76.e.0" text="Do not use" type="Caution_Interaction"/><entity charOffset="16:52" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.76.e.2" text="angiotensin receptor blockers (ARBs)" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="use with angiotensin receptor blockers (ARBs)" preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><mmtx cui="C0815017" phraseText="use with angiotensin receptor blockers (ARBs)" preferredWord="Angiotensin Receptor Antagonists" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="56:78" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.76.e.3" text="ACE inhibitors (ACEIs)" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors (ACEIs) in patients" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="96:104" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.76.e.4" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes" preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes" preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.76.ddi.1"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.76.e.0"><relations><relation type="hasContext"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.76.e.4"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.75" text="Tekamlo is contraindicated in patients with known hypersensitivity to any of the components."><entity charOffset="0:7" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.75.e.0" text="Tekamlo" type="Drug"><Normalization><mmtx cui="C2939825" phraseText="Tekamlo" preferredWord="Tekamlo" semType="phsu"/></Normalization></entity></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.76.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.76.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.76.e.2" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.76.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.76.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.76.e.3"/></sentence><sentence biomedicalEntities="2" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.79" lineNumber="80" text="&lt;item&gt;Avoid concomitant use with ARBs or ACEI in patients with renal impairment (GFR 60 mL/min) (5.2)." type="irregular"><entity charOffset="6:11" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.79.e.0" text="Avoid" type="Caution_Interaction"/><entity charOffset="33:37" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.79.e.2" text="ARBs" type="Drug_Class"><Normalization><RxNorm RxCui="1149617"/></Normalization></entity><entity charOffset="41:45" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.79.e.3" text="ACEI" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="63:79" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.79.e.4" text="renal impairment" type="SPAN"><Normalization><mmtx cui="C0035078" phraseText="with renal impairment" preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="with renal impairment" preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.79.ddi.1"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.79.e.0"><relations><relation type="hasContext"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.79.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.79.e.3"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.75" text="Tekamlo is contraindicated in patients with known hypersensitivity to any of the components."><entity charOffset="0:7" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.75.e.0" text="Tekamlo" type="Drug"><Normalization><mmtx cui="C2939825" phraseText="Tekamlo" preferredWord="Tekamlo" semType="phsu"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.76" text="Do not use with angiotensin receptor blockers (ARBs) or ACE inhibitors (ACEIs) in patients with diabetes (4)"/><middleSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.77" text="Known hypersensitivity to any component (4)"/><middleSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.78" text="WARNINGS AND PRECAUTIONS SECTION"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.79.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.79.e.2" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.79.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.79.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.79.e.2"/></sentence><sentence biomedicalEntities="1" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.84" lineNumber="86" text="&lt;item&gt;Increased angina or myocardial infarction with calcium channel blockers may occur upon dosage initiation or increase. " type="irregular"><entity charOffset="16:22" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.84.e.0" text="angina" type="Specific_Interaction"><Normalization><mmtx cui="C0002962" phraseText="&gt;Increased angina" preferredWord="Angina Pectoris" semType="sosy"/></Normalization></entity><entity charOffset="26:47" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.84.e.2" text="myocardial infarction" type="Specific_Interaction"><Normalization><mmtx cui="C0027051" phraseText="myocardial infarction with calcium channel blockers" preferredWord="Myocardial Infarction" semType="dsyn"/></Normalization></entity><entity charOffset="53:77" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.84.e.4" text="calcium channel blockers" type="Drug_Class"><Normalization><mmtx cui="C0006684" phraseText="myocardial infarction with calcium channel blockers" preferredWord="Calcium Channel Blockers" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.84.ddi.1"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.84.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.84.e.4"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.75" text="Tekamlo is contraindicated in patients with known hypersensitivity to any of the components."><entity charOffset="0:7" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.75.e.0" text="Tekamlo" type="Drug"><Normalization><mmtx cui="C2939825" phraseText="Tekamlo" preferredWord="Tekamlo" semType="phsu"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.76" text="Do not use with angiotensin receptor blockers (ARBs) or ACE inhibitors (ACEIs) in patients with diabetes (4)"/><middleSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.77" text="Known hypersensitivity to any component (4)"/><middleSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.78" text="WARNINGS AND PRECAUTIONS SECTION"/><middleSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.79" text="&lt;item&gt;Avoid concomitant use with ARBs or ACEI in patients with renal impairment (GFR 60 mL/min) (5.2)."/><middleSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.80" text="&lt;item&gt;Anaphylactic Reactions and Head and Neck Angioedema: Discontinue Tekamlo and monitor until signs and symptoms resolve. "/><middleSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.81" text="(5.3)."/><middleSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.82" text="&lt;item&gt;Hypotension in volume- and/or salt-depleted patients: Correct imbalances before initiating therapy with Tekamlo. "/><middleSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.83" text="(5.4)."/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.84.ddi.2"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.84.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.84.e.4"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.75" text="Tekamlo is contraindicated in patients with known hypersensitivity to any of the components."><entity charOffset="0:7" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.75.e.0" text="Tekamlo" type="Drug"><Normalization><mmtx cui="C2939825" phraseText="Tekamlo" preferredWord="Tekamlo" semType="phsu"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.76" text="Do not use with angiotensin receptor blockers (ARBs) or ACE inhibitors (ACEIs) in patients with diabetes (4)"/><middleSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.77" text="Known hypersensitivity to any component (4)"/><middleSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.78" text="WARNINGS AND PRECAUTIONS SECTION"/><middleSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.79" text="&lt;item&gt;Avoid concomitant use with ARBs or ACEI in patients with renal impairment (GFR 60 mL/min) (5.2)."/><middleSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.80" text="&lt;item&gt;Anaphylactic Reactions and Head and Neck Angioedema: Discontinue Tekamlo and monitor until signs and symptoms resolve. "/><middleSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.81" text="(5.3)."/><middleSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.82" text="&lt;item&gt;Hypotension in volume- and/or salt-depleted patients: Correct imbalances before initiating therapy with Tekamlo. "/><middleSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.83" text="(5.4)."/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.84.e.4"/></sentence><sentence biomedicalEntities="3" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95" lineNumber="95" text="Tekamlo is contraindicated in patients with diabetes who are receiving ARBs or ACEIs because of the increased risk of renal impairment, hyperkalemia, and hypotension see Contraindications (4) and Clinical Studies (14.2)." type="regular"><entity charOffset="44:52" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.0" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes" preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes" preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><entity charOffset="11:26" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.1" text="contraindicated" type="Caution_Interaction"/><entity charOffset="71:75" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.3" text="ARBs" type="Drug_Class"><Normalization><RxNorm RxCui="1149617"/></Normalization></entity><entity charOffset="79:84" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.4" text="ACEIs" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="0:7" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.5" text="Tekamlo" type="Drug"><Normalization><mmtx cui="C2939825" phraseText="Tekamlo" preferredWord="Tekamlo" semType="phsu"/><RxNorm RxCui="1372707"/></Normalization></entity><entity charOffset="11:26" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.6" text="contraindicated" type="SPAN"/><entity charOffset="118:134" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.7" text="renal impairment" type="Specific_Interaction"><Normalization><mmtx cui="C0035078" phraseText="ACEIs because of the increased risk of renal impairment," preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="ACEIs because of the increased risk of renal impairment," preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><entity charOffset="136:148" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.9" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="154:165" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.11" text="hypotension" type="Specific_Interaction"/><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.ddi.1"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.1"><relations><relation type="hasSeverity"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.6"/></relation><relation type="hasContext"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.4"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.ddi.2"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.7"><relations><relation type="hasContext"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.4"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.ddi.3"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.9"><relations><relation type="hasContext"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.4"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.ddi.4"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.11"><relations><relation type="hasContext"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.0" ddi="true" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.5" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.3" severity="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.6" trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.1" type="Caution_Interaction"/><pair context="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.0" ddi="true" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.5" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.4" severity="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.6" trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.1" type="Caution_Interaction"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.3" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.95.e.4"/></sentence><sentence biomedicalEntities="3" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.96" lineNumber="96" text="Avoid use of Tekamlo with ARBs or ACEIs in patients with moderate renal impairment (GFR 60 ml/min)." type="regular"><entity charOffset="0:5" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.96.e.0" text="Avoid" type="Caution_Interaction"/><entity charOffset="13:20" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.96.e.2" text="Tekamlo" type="Drug"><Normalization><mmtx cui="C2939825" phraseText="use of Tekamlo" preferredWord="Tekamlo" semType="phsu"/><RxNorm RxCui="1372707"/></Normalization></entity><entity charOffset="26:30" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.96.e.3" text="ARBs" type="Drug_Class"><Normalization><RxNorm RxCui="1149617"/></Normalization></entity><entity charOffset="34:39" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.96.e.4" text="ACEIs" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="66:82" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.96.e.5" text="renal impairment" type="SPAN"><Normalization><mmtx cui="C0035078" phraseText="with moderate renal impairment" preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="with moderate renal impairment" preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.96.ddi.1"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.96.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.96.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.96.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.96.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.96.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.96.e.5" ddi="true" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.96.e.2" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.96.e.3" trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.96.e.0" type="Caution_Interaction"/><pair context="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.96.e.5" ddi="true" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.96.e.2" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.96.e.4" trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.96.e.0" type="Caution_Interaction"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.96.e.3" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.96.e.4"/></sentence><sentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.99" text="This may occur at any time during treatment and has occurred in patients with and without a history of angioedema with ACE inhibitors or angiotensin receptor antagonists. " type="negative"><entity charOffset="119:133" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.99.e.0" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="with ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="137:169" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.99.e.1" text="angiotensin receptor antagonists" type="Biomedical_Entity"><Normalization><mmtx cui="C0815017" phraseText="angiotensin receptor antagonists." preferredWord="Angiotensin Receptor Antagonists" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.99.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.99.e.1"/></sentence><sentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.102" text="Patients who experience these effects, even without respiratory distress, require prolonged observation and appropriate monitoring measures since treatment with antihistamines and corticosteroids may not be sufficient to prevent respiratory involvement. " type="negative"><entity charOffset="161:175" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.102.e.0" text="antihistamines" type="Biomedical_Entity"><Normalization><mmtx cui="C0019590" phraseText="treatment with antihistamines" preferredWord="Histamine Antagonists" semType="phsu, orch"/><RxNorm RxCui="967"/></Normalization></entity><entity charOffset="180:195" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.102.e.1" text="corticosteroids" type="Biomedical_Entity"><Normalization><mmtx cui="C0001617" phraseText="corticosteroids" preferredWord="Adrenal Cortex Hormones" semType="strd, phsu, horm"/><RxNorm RxCui="1427675"/></Normalization></entity><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.102.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.102.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.105" lineNumber="100" text="In patients with an activated renin-angiotensin-aldosterone system, such as volume- and/or salt-depleted patients receiving high doses of diuretics, symptomatic hypotension may occur in patients receiving renin-angiotensin-aldosterone system (RAAS) blockers. " type="regular"><entity charOffset="205:257" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.105.e.0" text="renin-angiotensin-aldosterone system (RAAS) blockers" type="Drug_Class"><Normalization><mmtx cui="C0035100" phraseText="receiving renin-angiotensin-aldosterone system (RAAS) blockers." preferredWord="Chymosin" semType="phsu, aapp, enzy"/><mmtx cui="C0003018" phraseText="receiving renin-angiotensin-aldosterone system (RAAS) blockers." preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><mmtx cui="C0002006" phraseText="receiving renin-angiotensin-aldosterone system (RAAS) blockers." preferredWord="Aldosterone" semType="strd, phsu, horm"/><RxNorm RxCui="9246"/></Normalization></entity><entity charOffset="76:83|96:113" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.105.e.1" text="volume- depleted patients" type="SPAN"/><entity charOffset="91:113" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.105.e.2" text="salt-depleted patients" type="SPAN"/><entity charOffset="3:66" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.105.e.3" text="patients with an activated renin-angiotensin-aldosterone system" type="SPAN"/><entity charOffset="149:172" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.105.e.4" text="symptomatic hypotension" type="Specific_Interaction"/><entity charOffset="138:147" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.105.e.6" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="high doses of diuretics," preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.105.ddi.1"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.105.e.4"><relations><relation type="hasContext"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.105.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.105.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.105.e.6"/></relation><relation type="hasObject"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.105.e.0"/></relation><relation type="hasContext"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.105.e.3"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.105.e.2, Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.105.e.1, Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.105.e.3" ddi="true" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.105.e.6" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.105.e.0" trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.105.e.4" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114" lineNumber="105" text="Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, severe heart failure, post-myocardial infarction or volume depletion) or patients receiving ARB, ACEI or non-steroidal anti-inflammatory (NSAID) therapy may be at particular risk for developing acute renal failure on Tekamlo see Contraindications (4), Warnings and Precautions (5.2), Clinical Studies (14.2). " type="regular"><entity charOffset="233:236" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114.e.0" text="ARB" type="Drug_Class"><Normalization><RxNorm RxCui="1149617"/></Normalization></entity><entity charOffset="238:242" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114.e.1" text="ACEI" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="246:285" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114.e.2" text="non-steroidal anti-inflammatory (NSAID)" type="Drug_Class"><Normalization><mmtx cui="C0003209" phraseText="non-steroidal anti-inflammatory (NSAID) therapy" preferredWord="Anti-Inflammatory Agents" semType="phsu"/><RxNorm RxCui="1005832"/></Normalization></entity><entity charOffset="335:354" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114.e.3" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="for developing acute renal failure" preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><entity charOffset="358:365" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114.e.5" text="Tekamlo" type="Drug"><Normalization><mmtx cui="C2939825" phraseText="on Tekamlo" preferredWord="Tekamlo" semType="phsu"/><RxNorm RxCui="1372707"/></Normalization></entity><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114.ddi.1"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114.e.1" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114.e.5" trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114.e.3" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114.e.5" trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114.e.3" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114.e.2" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114.e.5" trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114.e.3" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114.e.1"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114.e.1" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114.e.2"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114.e.2"/></sentence><sentence biomedicalEntities="0" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.115" lineNumber="105" text="Consider withholding or discontinuing therapy in patients who develop a clinically significant decrease in renal function." type="irregular"><entity charOffset="9:20" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.115.e.0" text="withholding" type="Caution_Interaction"/><entity charOffset="24:37" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.115.e.2" text="discontinuing" type="Caution_Interaction"/><entity charOffset="49:121" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.115.e.4" text="patients who develop a clinically significant decrease in renal function" type="SPAN"/><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.115.ddi.1"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.115.e.0"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114" text="Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, severe heart failure, post-myocardial infarction or volume depletion) or patients receiving ARB, ACEI or non-steroidal anti-inflammatory (NSAID) therapy may be at particular risk for developing acute renal failure on Tekamlo see Contraindications (4), Warnings and Precautions (5.2), Clinical Studies (14.2). "><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114.e.1"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114" text="Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, severe heart failure, post-myocardial infarction or volume depletion) or patients receiving ARB, ACEI or non-steroidal anti-inflammatory (NSAID) therapy may be at particular risk for developing acute renal failure on Tekamlo see Contraindications (4), Warnings and Precautions (5.2), Clinical Studies (14.2). "><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114.e.0"/></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114" text="Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, severe heart failure, post-myocardial infarction or volume depletion) or patients receiving ARB, ACEI or non-steroidal anti-inflammatory (NSAID) therapy may be at particular risk for developing acute renal failure on Tekamlo see Contraindications (4), Warnings and Precautions (5.2), Clinical Studies (14.2). "><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114.e.5"/></ellipsisSentence></relation><relation type="hasContext"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.115.e.4"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114" text="Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, severe heart failure, post-myocardial infarction or volume depletion) or patients receiving ARB, ACEI or non-steroidal anti-inflammatory (NSAID) therapy may be at particular risk for developing acute renal failure on Tekamlo see Contraindications (4), Warnings and Precautions (5.2), Clinical Studies (14.2). "><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114.e.2"/></ellipsisSentence></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.115.ddi.2"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.115.e.2"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114" text="Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, severe heart failure, post-myocardial infarction or volume depletion) or patients receiving ARB, ACEI or non-steroidal anti-inflammatory (NSAID) therapy may be at particular risk for developing acute renal failure on Tekamlo see Contraindications (4), Warnings and Precautions (5.2), Clinical Studies (14.2). "><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114.e.1"/></ellipsisSentence></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114" text="Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, severe heart failure, post-myocardial infarction or volume depletion) or patients receiving ARB, ACEI or non-steroidal anti-inflammatory (NSAID) therapy may be at particular risk for developing acute renal failure on Tekamlo see Contraindications (4), Warnings and Precautions (5.2), Clinical Studies (14.2). "><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114.e.0"/></ellipsisSentence></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114" text="Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, severe heart failure, post-myocardial infarction or volume depletion) or patients receiving ARB, ACEI or non-steroidal anti-inflammatory (NSAID) therapy may be at particular risk for developing acute renal failure on Tekamlo see Contraindications (4), Warnings and Precautions (5.2), Clinical Studies (14.2). "><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114.e.5"/></ellipsisSentence></relation><relation type="hasContext"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.115.e.4"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114" text="Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, severe heart failure, post-myocardial infarction or volume depletion) or patients receiving ARB, ACEI or non-steroidal anti-inflammatory (NSAID) therapy may be at particular risk for developing acute renal failure on Tekamlo see Contraindications (4), Warnings and Precautions (5.2), Clinical Studies (14.2). "><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.114.e.2"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="3" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.116" lineNumber="106" text="When aliskiren was given with cyclosporine or itraconazole, the blood concentrations of aliskiren were significantly increased. " type="regular"><entity charOffset="30:42" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.116.e.0" text="cyclosporine" type="Drug"><Normalization><mmtx cui="C0010592" phraseText="given with cyclosporine" preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><entity charOffset="46:58" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.116.e.1" text="itraconazole" type="Drug"><Normalization><mmtx cui="C0064113" phraseText="itraconazole," preferredWord="Itraconazole" semType="phsu, orch"/><RxNorm RxCui="28031"/></Normalization></entity><entity charOffset="64:84|117:126" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.116.e.2" text="blood concentrations increased" type="Increase_Interaction"/><entity charOffset="88:97" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.116.e.4" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="the blood concentrations of aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><mmtx cui="C1120110" phraseText="the blood concentrations of aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.116.ddi.1"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.116.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.116.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.116.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.116.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.116.e.1" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.116.e.4" trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.116.e.2" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.116.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.116.e.4" trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.116.e.2" type="Increase_Interaction"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.116.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.116.e.1"/></sentence><sentence biomedicalEntities="3" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.117" lineNumber="106" text="Avoid concomitant use of aliskiren with cyclosporine or intraconazole see Drug Interactions (7)." type="regular"><entity charOffset="0:5" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.117.e.0" text="Avoid" type="Caution_Interaction"/><entity charOffset="25:34" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.117.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="concomitant use of aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="40:52" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.117.e.3" text="cyclosporine" type="Drug"><Normalization><mmtx cui="C0010592" phraseText="with cyclosporine" preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><entity charOffset="56:69" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.117.e.4" text="intraconazole" type="Drug"><Normalization><RxNorm RxCui="28031"/></Normalization></entity><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.117.ddi.1"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.117.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.117.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.117.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.117.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.117.e.2" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.117.e.3" trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.117.e.0" type="Caution_Interaction"/><pair ddi="true" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.117.e.2" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.117.e.4" trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.117.e.0" type="Caution_Interaction"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.117.e.3" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.117.e.4"/></sentence><sentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.119" text="Monitor serum potassium periodically in patients receiving aliskiren. " type="negative"><entity charOffset="59:68" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.119.e.0" text="aliskiren" type="Biomedical_Entity"><Normalization><mmtx cui="C1120110" phraseText="aliskiren." preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="14:23" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.119.e.1" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="Monitor serum potassium periodically in patients" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.119.e.1" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.119.e.0"/></sentence><sentence biomedicalEntities="5" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121" lineNumber="108" text="Risk factors for the development of hyperkalemia include renal insufficiency, diabetes, combination use with ARBs or ACEI see Contraindications (4), Warnings and Precautions (5.2), and Clinical Studies (14.2), NSAIDs, or potassium supplements or potassium sparing diuretics." type="irregular"><entity charOffset="36:48" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.0" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="109:113" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.2" text="ARBs" type="Drug_Class"><Normalization><RxNorm RxCui="1149617"/></Normalization></entity><entity charOffset="117:121" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.3" text="ACEI" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="210:216" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.4" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="NSAIDs," preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="221:242" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.5" text="potassium supplements" type="Drug_Class"><Normalization><mmtx cui="C0304475" phraseText="potassium supplements" preferredWord="Potassium supplement" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="246:273" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.6" text="potassium sparing diuretics" type="Drug_Class"><Normalization><mmtx cui="C0304490" phraseText="potassium sparing diuretics." preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="8588"/></Normalization></entity><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.ddi.1"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.5"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.119" text="Monitor serum potassium periodically in patients receiving aliskiren. "><entity charOffset="59:68" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.119.e.0" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren." preferredWord="aliskiren" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.120" text="Drugs that affect the renin-angiotensin system can cause hyperkalemia. "/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.6"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.2" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.4"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.4" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.5"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.4" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.6"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.3" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.4"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.2" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.5"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.2" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.6"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.2" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.3"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.5" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.6"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.3" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.5"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.3" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.6"/><pair ddi="true" e1="labelDrug" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.4"/><pair ddi="true" e1="labelDrug" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.5"/><pair ddi="true" e1="labelDrug" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.6"/><pair ddi="true" e1="labelDrug" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.121.e.3"/></sentence><sentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.123" text="No drug interaction studies have been conducted with Tekamlo and other drugs, although studies with the individual aliskiren and amlodipine besylate components are described below." type="negative"><entity charOffset="53:60" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.123.e.0" text="tekamlo" type="Biomedical_Entity"><Normalization><mmtx cui="C2939825" phraseText="conducted with Tekamlo" preferredWord="Tekamlo" semType="phsu"/><RxNorm RxCui="1372707"/></Normalization></entity><entity charOffset="129:148" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.123.e.1" text="amlodipine besylate" type="Biomedical_Entity"><Normalization><mmtx cui="C0354468" phraseText="amlodipine besylate components" preferredWord="Amlodipine Besylate" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><entity charOffset="115:124" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.123.e.2" text="aliskiren" type="Biomedical_Entity"><Normalization><mmtx cui="C1120110" phraseText="studies with the individual aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.123.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.123.e.1"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.123.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.123.e.2"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.123.e.2" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.123.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.124" lineNumber="113" text="Cyclosporin e : Avoid co-administration of cyclosporine with aliskiren." type="regular"><entity charOffset="43:55" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.124.e.0" text="cyclosporine" type="Drug"><Normalization><mmtx cui="C0010592" phraseText="co-administration of cyclosporine" preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><entity charOffset="61:70" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.124.e.1" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="with aliskiren." preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="16:21" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.124.e.2" text="Avoid" type="Caution_Interaction"/><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.124.ddi.1"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.124.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.124.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.124.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.124.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.124.e.1" trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.124.e.2" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.125" lineNumber="114" text="Itraconazole: Avoid co-administration of itraconazole with aliskiren see Clinical Pharmacology (12.3." type="regular"><entity charOffset="14:19" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.125.e.0" text="Avoid" type="Caution_Interaction"/><entity charOffset="41:53" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.125.e.2" text="itraconazole" type="Drug"><Normalization><mmtx cui="C0064113" phraseText="co-administration of itraconazole" preferredWord="Itraconazole" semType="phsu, orch"/><RxNorm RxCui="28031"/></Normalization></entity><entity charOffset="59:68" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.125.e.3" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="with aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.125.ddi.1"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.125.e.0"><relations><relation type="hasObject"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.125.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.125.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.125.e.2" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.125.e.3" trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.125.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.126" lineNumber="115" text="Non-Steroidal Anti-Inflammatory Agents(NSAIDs) including selective Cyclooxygenase-2 inhibitors (COX-2 inhibitors): In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDs, including selective COX-2 inhibitors with agents that affect the renin-angiotensin system, including aliskiren, may result in deterioration of renal function, including possible acute renal failure. " type="regular"><entity charOffset="135:142" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.126.e.0" text="elderly" type="SPAN"/><entity charOffset="144:159" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.126.e.1" text="volume-depleted" type="SPAN"/><entity charOffset="207:233" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.126.e.2" text="compromised renal function" type="SPAN"/><entity charOffset="256:262" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.126.e.3" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="co-administration of NSAIDs," preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="274:300" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.126.e.4" text="selective COX-2 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1257954" phraseText="selective COX-2 inhibitors with agents" preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="306:353" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.126.e.5" text="agents that affect the renin-angiotensin system" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="selective COX-2 inhibitors with agents" preferredWord="Pharmacologic Substance" semType="phsu"/><mmtx cui="C0035100" phraseText="the renin-angiotensin system," preferredWord="Chymosin" semType="phsu, aapp, enzy"/><mmtx cui="C0003018" phraseText="the renin-angiotensin system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="126263"/></Normalization></entity><entity charOffset="365:374" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.126.e.6" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren," preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="390:421" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.126.e.7" text="deterioration of renal function" type="Specific_Interaction"/><entity charOffset="442:461" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.126.e.9" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="possible acute renal failure." preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><classClassMembership drugClass="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.126.e.4"/><drugClassMembership drug="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.126.e.6" drugClass="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.126.e.5"/><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.126.ddi.1"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.126.e.7"><relations><relation type="hasContext"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.126.e.1"/></relation><relation type="hasContext"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.126.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.126.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.126.e.5"/></relation><relation type="hasContext"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.126.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.126.ddi.2"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.126.e.9"><relations><relation type="hasContext"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.126.e.1"/></relation><relation type="hasContext"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.126.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.126.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.126.e.5"/></relation><relation type="hasContext"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.126.e.0"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.126.e.1, Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.126.e.2, Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.126.e.0" ddi="true" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.126.e.3" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.126.e.5" trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.126.e.7" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.128" lineNumber="115" text="Monitor renal function periodically in patients receiving aliskiren and NSAID therapy." type="regular"><entity charOffset="0:7" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.128.e.0" text="Monitor" type="Caution_Interaction"/><entity charOffset="58:67" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.128.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="72:77" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.128.e.3" text="NSAID" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="NSAID therapy." preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.128.ddi.1"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.128.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.128.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.128.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.128.e.2" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.128.e.3" trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.128.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.129" lineNumber="116" text="The antihypertensive effect of aliskiren may be attenuated by NSAIDs." type="regular"><entity charOffset="31:40" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.129.e.0" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="The antihypertensive effect of aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="62:68" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.129.e.1" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="attenuated by NSAIDs." preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="4:27|48:58" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.129.e.2" text="antihypertensive effect attenuated" type="Specific_Interaction"/><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.129.ddi.1"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.129.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.129.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.129.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.129.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.129.e.1" trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.129.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.131" lineNumber="118" text="Simvastatin: Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin. " type="regular"><entity charOffset="62:93" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.131.e.0" text="increases the systemic exposure" type="Increase_Interaction"/><entity charOffset="51:61" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.131.e.2" text="amlodipine" type="Drug"><Normalization><mmtx cui="C0051696" phraseText="with amlodipine" preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><entity charOffset="97:108" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.131.e.3" text="simvastatin" type="Drug"><Normalization><mmtx cui="C0074554" phraseText="the systemic exposure of simvastatin." preferredWord="Simvastatin" semType="phsu, orch"/><RxNorm RxCui="36567"/></Normalization></entity><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.131.ddi.1"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.131.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.131.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.131.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.131.e.2" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.131.e.3" trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.131.e.0" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.132" lineNumber="118" text="Limit the dose of simvastatin in patients on amlodipine to 20 mg daily." type="regular"><entity charOffset="0:14" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.132.e.0" text="Limit the dose" type="Caution_Interaction"/><entity charOffset="18:29" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.132.e.2" text="simvastatin" type="Drug"><Normalization><mmtx cui="C0074554" phraseText="the dose of simvastatin" preferredWord="Simvastatin" semType="phsu, orch"/><RxNorm RxCui="36567"/></Normalization></entity><entity charOffset="45:55" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.132.e.3" text="amlodipine" type="Drug"><Normalization><mmtx cui="C0051696" phraseText="on amlodipine" preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.132.ddi.1"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.132.e.0"><relations><relation type="hasObject"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.132.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.132.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.132.e.2" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.132.e.3" trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.132.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.133" lineNumber="119" text="CYP3A4 Inhibitors: Co-administration with CYP3A inhibitors (moderate and strong) result in increased systemic exposure to amlodipine warranting dose reduction. " type="regular"><entity charOffset="42:58|60:68" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.133.e.0" text="CYP3A inhibitors moderate" type="Drug_Class"><Normalization><RxNorm RxCui="24348"/></Normalization></entity><entity charOffset="42:58|73:79" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.133.e.1" text="CYP3A inhibitors strong" type="Drug_Class"><Normalization><RxNorm RxCui="24348"/></Normalization></entity><entity charOffset="91:118" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.133.e.2" text="increased systemic exposure" type="Increase_Interaction"/><entity charOffset="122:132" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.133.e.4" text="amlodipine" type="Drug"><Normalization><mmtx cui="C0051696" phraseText="result in increased systemic exposure to amlodipine warranting dose reduction." preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><entity charOffset="144:158" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.133.e.5" text="dose reduction" type="Increase_Interaction"/><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.133.ddi.1"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.133.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.133.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.133.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.133.e.4"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.133.ddi.2"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.133.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.133.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.133.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.133.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.133.e.1" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.133.e.4" trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.133.e.2" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.133.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.133.e.4" trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.133.e.2" type="Increase_Interaction"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.133.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.133.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.134" lineNumber="119" text="Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A4 inhibitors to determine the need for dose adjustment." type="regular"><entity charOffset="24:35" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.134.e.0" text="hypotension" type="Specific_Interaction"/><entity charOffset="40:45" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.134.e.2" text="edema" type="Specific_Interaction"/><entity charOffset="51:61" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.134.e.4" text="amlodipine" type="Drug"><Normalization><mmtx cui="C0051696" phraseText="amlodipine" preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><entity charOffset="86:103" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.134.e.5" text="CYP3A4 inhibitors" type="Drug_Class"><Normalization><RxNorm RxCui="340933"/></Normalization></entity><entity charOffset="130:145" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.134.e.6" text="dose adjustment" type="Caution_Interaction"/><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.134.ddi.1"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.134.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.134.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.134.e.4"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.134.ddi.2"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.134.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.134.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.134.e.4"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.134.ddi.3"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.134.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.134.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.134.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.134.e.4" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.134.e.5" trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.134.e.0" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.136" lineNumber="120" text="Blood pressure should be monitored when amlodipine is co-administered with CYP3A4 inducers." type="regular"><entity charOffset="25:34" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.136.e.0" text="monitored" type="Caution_Interaction"/><entity charOffset="40:50" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.136.e.2" text="amlodipine" type="Drug"><Normalization><mmtx cui="C0051696" phraseText="amlodipine" preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><entity charOffset="75:90" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.136.e.3" text="CYP3A4 inducers" type="Drug_Class"><Normalization><RxNorm RxCui="340933"/></Normalization></entity><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.136.ddi.1"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.136.e.0"><relations><relation type="hasObject"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.136.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.136.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.136.e.2" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.136.e.3" trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.136.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.137" lineNumber="123" text="&lt;item&gt;Cyclosporine: Avoid concomitant use (7, 12.3)." type="irregular"><entity charOffset="20:25" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.137.e.0" text="Avoid" type="Caution_Interaction"/><entity charOffset="6:18" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.137.e.2" text="Cyclosporine" type="Drug"><Normalization><mmtx cui="C0010592" phraseText="&gt;Cyclosporine" preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.137.ddi.1"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.137.e.0"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.136" text="Blood pressure should be monitored when amlodipine is co-administered with CYP3A4 inducers."><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.136.e.2"/></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.137.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.137.e.2"/></sentence><sentence biomedicalEntities="1" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.138" lineNumber="125" text="&lt;item&gt;Itraconazole: Avoid concomitant use (7, 12.3)" type="irregular"><entity charOffset="20:25" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.138.e.0" text="Avoid" type="Caution_Interaction"/><entity charOffset="6:18" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.138.e.2" text="Itraconazole" type="Drug"><Normalization><mmtx cui="C0064113" phraseText="&gt;Itraconazole" preferredWord="Itraconazole" semType="phsu, orch"/><RxNorm RxCui="28031"/></Normalization></entity><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.138.ddi.1"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.138.e.0"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.136" text="Blood pressure should be monitored when amlodipine is co-administered with CYP3A4 inducers."><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.136.e.2"/></ellipsisSentence><middleSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.137" text="&lt;item&gt;Cyclosporine: Avoid concomitant use (7, 12.3)."/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.138.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.138.e.2"/></sentence><sentence biomedicalEntities="1" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.139" lineNumber="127" text="&lt;item&gt;NSAIDs use may lead to increased risk of renal impairment and loss of antihypertensive effect (7)." type="irregular"><entity charOffset="6:12" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.139.e.0" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="&gt;NSAIDs" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="47:63" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.139.e.1" text="renal impairment" type="Specific_Interaction"><Normalization><mmtx cui="C0035078" phraseText="lead to increased risk of renal impairment" preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="lead to increased risk of renal impairment" preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><entity charOffset="68:99" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.139.e.3" text="loss of antihypertensive effect" type="Specific_Interaction"/><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.139.ddi.1"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.139.e.1"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.136" text="Blood pressure should be monitored when amlodipine is co-administered with CYP3A4 inducers."><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.136.e.2"/></ellipsisSentence><middleSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.137" text="&lt;item&gt;Cyclosporine: Avoid concomitant use (7, 12.3)."/><middleSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.138" text="&lt;item&gt;Itraconazole: Avoid concomitant use (7, 12.3)"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.139.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.139.ddi.2"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.139.e.3"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.136" text="Blood pressure should be monitored when amlodipine is co-administered with CYP3A4 inducers."><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.136.e.2"/></ellipsisSentence><middleSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.137" text="&lt;item&gt;Cyclosporine: Avoid concomitant use (7, 12.3)."/><middleSentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.138" text="&lt;item&gt;Itraconazole: Avoid concomitant use (7, 12.3)"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.139.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.139.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.140" lineNumber="129" text="&lt;item&gt;If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7)" type="regular"><entity charOffset="9:20" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.140.e.0" text="simvastatin" type="Drug"><Normalization><mmtx cui="C0074554" phraseText="simvastatin" preferredWord="Simvastatin" semType="phsu, orch"/><RxNorm RxCui="36567"/></Normalization></entity><entity charOffset="45:55" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.140.e.1" text="amlodipine" type="Drug"><Normalization><mmtx cui="C0051696" phraseText="co-administered with amlodipine," preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><entity charOffset="57:76" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.140.e.2" text="do not exceed doses" type="Caution_Interaction"/><drugInteraction id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.140.ddi.1"><interaction trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.140.e.2"><relations><relation type="hasObject"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.140.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.140.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.140.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.140.e.1" trigger="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.140.e.2" type="Caution_Interaction"/></sentence><sentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.142" text="Tekamlo is a single tablet for oral administration of aliskiren hemifumarate (an orally active, nonpeptide, potent direct renin inhibitor) and amlodipine besylate (a dihydropyridine calcium channel blocker)." type="negative"><entity charOffset="166:205" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.142.e.0" text="dihydropyridine calcium channel blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C2945601" phraseText="a dihydropyridine calcium channel blocker" preferredWord="Dihydropyridine Calcium Channel Blocker [EPC]" semType="phsu"/><RxNorm RxCui="3427"/></Normalization></entity><entity charOffset="0:7" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.142.e.1" text="tekamlo" type="Biomedical_Entity"><Normalization><mmtx cui="C2939825" phraseText="Tekamlo" preferredWord="Tekamlo" semType="phsu"/><RxNorm RxCui="1372707"/></Normalization></entity><entity charOffset="20:63" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.142.e.2" text="tablet oral aliskiren" type="Biomedical_Entity"><Normalization><mmtx cui="C1875984" phraseText="a single tablet for oral administration of aliskiren hemifumarate" preferredWord="aliskiren Oral Tablet" semType="clnd"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="143:162" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.142.e.3" text="amlodipine besylate" type="Biomedical_Entity"><Normalization><mmtx cui="C0354468" phraseText="amlodipine besylate" preferredWord="Amlodipine Besylate" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><entity charOffset="115:137" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.142.e.4" text="direct renin inhibitor" type="Biomedical_Entity"><Normalization><mmtx cui="C1950687" phraseText="potent direct renin inhibitor" preferredWord="DIRECT RENIN INHIBITOR" semType="phsu"/><RxNorm RxCui="3525"/></Normalization></entity><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.142.e.1" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.142.e.0"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.142.e.2" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.142.e.0"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.142.e.3" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.142.e.0"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.142.e.4" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.142.e.0"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.142.e.1" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.142.e.2"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.142.e.1" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.142.e.3"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.142.e.1" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.142.e.4"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.142.e.2" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.142.e.3"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.142.e.2" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.142.e.4"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.142.e.4" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.142.e.3"/></sentence><sentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.147" text="It is highly soluble in water, and freely soluble in methanol, ethanol and isopropanol." type="negative"><entity charOffset="75:86" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.147.e.0" text="isopropanol" type="Biomedical_Entity"><Normalization><mmtx cui="C0022237" phraseText="isopropanol." preferredWord="Isopropyl Alcohol" semType="phsu, orch"/><RxNorm RxCui="797541"/></Normalization></entity><entity charOffset="53:61" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.147.e.1" text="methanol" type="Biomedical_Entity"><Normalization><mmtx cui="C0001963" phraseText="freely soluble in methanol," preferredWord="Methanol" semType="phsu, orch, hops"/><RxNorm RxCui="1310568"/></Normalization></entity><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.147.e.1" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.147.e.0"/></sentence><sentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.152" text="Tekamlo tablets are formulated for oral administration to contain aliskiren hemifumarate and amlodipine besylate providing for the following available combinations: 150 mg/5 mg, 150 mg/10 mg, 300 mg/5 mg and 300 mg/10 mg aliskiren /amlodipine. " type="negative"><entity charOffset="66:88" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.152.e.0" text="aliskiren hemifumarate" type="Biomedical_Entity"><Normalization><mmtx cui="C1879678" phraseText="aliskiren hemifumarate" preferredWord="aliskiren hemifumarate" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="0:7" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.152.e.1" text="tekamlo" type="Biomedical_Entity"><Normalization><mmtx cui="C2939825" phraseText="Tekamlo tablets" preferredWord="Tekamlo" semType="phsu"/><RxNorm RxCui="1372707"/></Normalization></entity><entity charOffset="93:112" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.152.e.2" text="amlodipine besylate" type="Biomedical_Entity"><Normalization><mmtx cui="C0354468" phraseText="amlodipine besylate providing for the following available combinations" preferredWord="Amlodipine Besylate" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><entity charOffset="221:242" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.152.e.3" text="aliskiren amlodipine" type="Biomedical_Entity"><Normalization><mmtx cui="C2937472" phraseText="300 mg/10 mg aliskiren /amlodipine." preferredWord="aliskiren / Amlodipine" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.152.e.1" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.152.e.0"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.152.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.152.e.2"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.152.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.152.e.3"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.152.e.1" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.152.e.2"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.152.e.1" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.152.e.3"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.152.e.2" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.152.e.3"/></sentence><sentence id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153" text="The inactive ingredients for all strengths of the tablets may contain colloidal silicon dioxide, crospovidone, hypromellose, iron oxide red, iron oxide yellow, magnesium stearate, microcrystalline cellulose, polyethylene glycol, povidone, talc, and titanium dioxide." type="negative"><entity charOffset="160:178" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.0" text="magnesium stearate" type="Biomedical_Entity"><Normalization><mmtx cui="C0126791" phraseText="magnesium stearate," preferredWord="Magnesium stearate" semType="phsu, lipd"/><RxNorm RxCui="6574"/></Normalization></entity><entity charOffset="141:151" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.1" text="iron oxide" type="Biomedical_Entity"><Normalization><mmtx cui="C0060240" phraseText="iron oxide yellow," preferredWord="ferric oxide" semType="inch, phsu"/><RxNorm RxCui="90176"/></Normalization></entity><entity charOffset="125:135" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.2" text="iron oxide" type="Biomedical_Entity"><Normalization><mmtx cui="C0060240" phraseText="iron oxide red," preferredWord="ferric oxide" semType="inch, phsu"/><RxNorm RxCui="90176"/></Normalization></entity><entity charOffset="180:206" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.3" text="microcrystalline cellulose" type="Biomedical_Entity"><Normalization><mmtx cui="C0669247" phraseText="microcrystalline cellulose," preferredWord="microcrystalline cellulose" semType="phsu, carb, bodm"/><RxNorm RxCui="1239123"/></Normalization></entity><entity charOffset="97:109" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.4" text="crospovidone" type="Biomedical_Entity"><Normalization><mmtx cui="C0728803" phraseText="crospovidone," preferredWord="Crospovidone" semType="phsu, orch"/><RxNorm RxCui="1310706"/></Normalization></entity><entity charOffset="111:123" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.5" text="hypromellose" type="Biomedical_Entity"><Normalization><mmtx cui="C0063242" phraseText="hypromellose," preferredWord="hypromellose" semType="phsu, carb"/><RxNorm RxCui="27334"/></Normalization></entity><entity charOffset="208:227" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.6" text="polyethylene glycol" type="Biomedical_Entity"><Normalization><mmtx cui="C0032483" phraseText="polyethylene glycol," preferredWord="Polyethylene Glycols" semType="phsu, bodm, orch"/><RxNorm RxCui="54961"/></Normalization></entity><entity charOffset="249:265" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.7" text="titanium dioxide" type="Biomedical_Entity"><Normalization><mmtx cui="C0076733" phraseText="titanium dioxide." preferredWord="titanium dioxide" semType="inch, phsu"/><RxNorm RxCui="1305547"/></Normalization></entity><entity charOffset="239:243" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.8" text="talc" type="Biomedical_Entity"><Normalization><mmtx cui="C0039267" phraseText="talc," preferredWord="Talc" semType="inch, phsu, bodm"/><RxNorm RxCui="10323"/></Normalization></entity><entity charOffset="229:237" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.9" text="povidone" type="Biomedical_Entity"><Normalization><mmtx cui="C0032856" phraseText="povidone," preferredWord="Povidone" semType="phsu, bodm, orch"/><RxNorm RxCui="8610"/></Normalization></entity><entity charOffset="70:95" id="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.10" text="colloidal silicon dioxide" type="Biomedical_Entity"><Normalization><mmtx cui="C0982384" phraseText="colloidal silicon dioxide," preferredWord="silicon dioxide, colloidal" semType="inch, phsu, bodm"/><RxNorm RxCui="221082"/></Normalization></entity><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.1" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.0"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.2" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.0"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.3"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.4" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.0"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.5" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.0"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.6"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.7"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.8"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.0" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.9"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.10" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.0"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.1" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.3"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.4" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.1"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.5" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.1"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.1" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.6"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.1" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.7"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.1" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.8"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.1" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.9"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.10" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.1"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.2" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.3"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.4" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.2"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.5" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.2"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.2" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.6"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.2" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.7"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.2" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.8"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.2" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.9"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.10" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.2"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.4" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.3"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.5" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.3"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.3" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.6"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.3" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.7"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.3" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.8"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.3" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.9"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.10" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.3"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.4" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.5"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.4" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.6"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.4" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.7"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.4" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.8"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.4" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.9"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.10" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.4"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.5" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.6"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.5" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.7"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.5" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.8"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.5" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.9"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.10" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.5"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.6" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.7"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.6" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.8"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.6" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.9"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.10" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.6"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.8" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.7"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.9" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.7"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.10" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.7"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.9" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.8"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.10" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.8"/><pair ddi="false" e1="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.10" e2="Dailymed.78a3bdb0-c945-45cf-b75d-066dbf1d152c.s.153.e.9"/></sentence><positiveExamples number="43"/><negativeExamples number="125"/></document>